Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELIGARD 22.5mg Efficacy and Safety in Prostate Cancer
NCT01511874Phase 4Completed
- Sponsor
- HanAll Biopharma
- Start
- Jan 2011
- Primary completion
- May 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leuprolide in prostate cancer (PCa), sponsored by HanAll Biopharma. Started Jan 2011; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01511874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511874.